Citations (215)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Wenhui Bai, Li Cheng, Liangkun Xiong, Maoming Wang, Hao Liu, Kaihuan Yu & Weixing Wang. (2022) Identification of Prognostic Genes in Hepatocellular Carcinoma. International Journal of General Medicine 15, pages 2895-2904.
Read now
Read now
Shengya Cao, Shuo Zhu, Wei Yin, Heng Xu, Jianzhong Wu & Qiang Wang. (2020) Relevance of EGFR Between Serum VEGF and MMP-9 in Primary Hepatocellular Carcinoma Patients with Transarterial Chemoembolization. OncoTargets and Therapy 13, pages 9407-9417.
Read now
Read now
Hongda Chen, Yue Zhang, Siwen Li, Ni Li, Yuhan Chen, Bei Zhang, Chunfeng Qu, Huiguo Ding, Jian Huang & Min Dai. (2018) Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma. Cancer Management and Research 10, pages 1947-1958.
Read now
Read now
Xiao-Ming Wu, Jun-Feng Wang, Jian-Song Ji, Ming-Gao Chen & Jian-Gang Song. (2017) Evaluation of efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma using magnetic resonance diffusion-weighted imaging. OncoTargets and Therapy 10, pages 1637-1643.
Read now
Read now
Caroline R Cartlidge, M R Abellona U, Alzhraa M A Alkhatib & Simon D Taylor-Robinson. (2017) The utility of biomarkers in hepatocellular carcinoma: review of urine-based 1H-NMR studies – what the clinician needs to know. International Journal of General Medicine 10, pages 431-442.
Read now
Read now
Zhiguo Zhang, Yanying Zhang, Yeying Wang, Lingling Xu & Wanju Xu. (2016) Alpha-fetoprotein-L3 and Golgi protein 73 may serve as candidate biomarkers for diagnosing alpha-fetoprotein-negative hepatocellular carcinoma. OncoTargets and Therapy 9, pages 123-129.
Read now
Read now
Yu Zhang, Xiaofeng Zhang, Jinling Zhang, Bin Sun, Lulu Zheng, Jun Li, Sixiu Liu, Guodong Sui & Zhengfeng Yin. (2016) Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay. Cancer Biology & Therapy 17:11, pages 1177-1187.
Read now
Read now
Sang Hoon Lee, Seung Up Kim, Jeong Won Jang, Si Hyun Bae, Sanghun Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn & Kwang–Hyub Han. (2015) Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma. OncoTargets and Therapy 8, pages 347-356.
Read now
Read now
Ilana Gory, Michael Fink, Sally Bell, Paul Gow, Amanda Nicoll, Virginia Knight, Anouk Dev, Anthony Rode, Michael Bailey, Wa Cheung, William Kemp & Stuart K. Roberts. (2015) Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study. Scandinavian Journal of Gastroenterology 50:5, pages 567-576.
Read now
Read now
Neveen Abd El Moneim Hussein, Mervat Abd El-Fattah El-Toukhy, Amany Hussein Kazem, Mahmoud El-Said Ali, Mohammad Abd El-Rahman Ahmad, Hossam Mahmoud Rashad Ghazy & Ahmed Mohamed Gamal El-Din. (2014) Protective and therapeutic effects of cannabis plant extract on liver cancer induced by dimethylnitrosamine in mice. Alexandria Journal of Medicine 50:3, pages 241-251.
Read now
Read now
Mi Sung Park, Kwang-Hyub Han & Seung Up Kim. (2014) Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease. Expert Review of Gastroenterology & Hepatology 8:5, pages 501-511.
Read now
Read now
Robert G Gish, Riccardo Lencioni, Adrian M Di Bisceglie, Jean-Luc Raoul & Vincenzo Mazzaferro. (2012) Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 6:2, pages 173-185.
Read now
Read now
Heath D. Skinner, Hadley J. Sharp, Ahmed O. Kaseb, Milind M. Javle, Jean Nicolas Vauthey, Eddie K. Abdalla, Marc E. Delclos, Prajnan Das, Christopher H. Crane & Sunil Krishnan. (2011) Radiation treatment outcomes for unresectable hepatocellular carcinoma. Acta Oncologica 50:8, pages 1191-1198.
Read now
Read now
Yi-ying Wu, Ling Zhu, Xiu-ying Ma, Zheng-jun Shao, Jian Chen, Xia-jing Chen, Li-hong Wan & Li-ming Zhou. (2011) The anti-proliferation effect of Aikete injection on hepatocellular carcinoma in vitro and in vivo. Pharmaceutical Biology 49:5, pages 531-538.
Read now
Read now
Articles from other publishers (201)
Junqi You, Haoming Xia, Ziyue Huang, Risheng He, Xudong Zhao, Jiali Chen, Sidi Liu, Yi Xu & Yunfu Cui. (2023) Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma. Frontiers in Oncology 13.
Crossref
Crossref
Xingxin Huang, Yuan‐E Lian, Lida Qiu, XunBin Yu, Zhenlin Zhan, Zheng Zhang, Xiong Zhang, Hongxin Lin, Shuoyu Xu, Jianxin Chen, Yannan Bai & Lianhuang Li. (2023) Detection of fibrotic changes in the progression of liver diseases by label‐free multiphoton imaging. Journal of Biophotonics.
Crossref
Crossref
Wanying Shen, Xiaofang Wei, Yangfang Li, Chenxiao Liu, Lanlan Ge, Jie Yao, Xiaobin Zeng & Xudong Tang. (2023) A Novel Caffeoylquinic Acid from Lonicera japonica Exerts Cytotoxic Activity by Blocking the YAP-CTGF Signaling Pathway in Hepatocellular Carcinoma. Revista Brasileira de Farmacognosia 33:4, pages 736-746.
Crossref
Crossref
Libo Sun, Hansheng Zhou, Xiaofei Zhao, Haitao Zhang, Yan Wang & Guangming Li. (2023) Small RNA sequencing identified miR-3180 as a potential prognostic biomarker for Chinese hepatocellular carcinoma patients. Frontiers in Genetics 14.
Crossref
Crossref
Ahmed M. Abou-Shanab, Ola A. Gaser, Radwa Ayman Salah & Nagwa El-Badri. 2023.
Jenny Drott, Bergthor Björnsson, Per Sandström & Carina Berterö. (2022) Experiences of Symptoms and Impact on Daily Life and Health in Hepatocellular Carcinoma Patients. Cancer Nursing 45:6, pages 430-437.
Crossref
Crossref
Neneng Ratnasari, Puji Lestari, Dede Renovaldi, Juwita Raditya Ningsih, Nanda Qoriansas, Tirta Wardana, Suharno Hakim, Nur Signa Aini Gumilas, Fahmi Indrarti, Catharina Triwikatmani, Putut Bayupurnama, Didik Setyo Heriyanto, Indwiani Astuti & Sofia Mubarika Harjana. (2022) Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients. PLOS ONE 17:2, pages e0263298.
Crossref
Crossref
Vo Hoang Xuan Dat, Bui Thi Huyen Nhung, Nguyen Ngoc Bao Chau, Pham Hung Cuong, Vo Duc Hieu, Nguyen Thi Minh Linh & Nguyen Bao Quoc. (2022) Identification of potential microRNA groups for the diagnosis of hepatocellular carcinoma (HCC) using microarray datasets and bioinformatics tools. Heliyon 8:2, pages e08987.
Crossref
Crossref
Yuanyuan Feng, Xinfang Tang, Changcheng Li, Ying Su, Xiaoyu Wang, Ning Li, Anna Zhang, Feng Jiang & Chuyan Wu. (2022) ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2022, pages 1-14.
Crossref
Crossref
Radwa Ayman Salah, Mohamed A. Nasr, Azza M. El-Derby, M. Abd Elkodous, Rania Hassan Mohamed, Nada El-Ekiaby, Aya Osama, Shimaa E. Elshenawy, Merna Hatem Mohamed Hamad, Sameh Magdeldin, Mahmoud M. Gabr, Ahmed I. Abdelaziz & Nagwa S. El-Badri. (2022) Hepatocellular carcinoma cell line-microenvironment induced cancer-associated phenotype, genotype and functionality in mesenchymal stem cells. Life Sciences 288, pages 120168.
Crossref
Crossref
Gustavo dos Santos Fernandes, Daniel Campos, Andre Ballalai, Rodrigo Palhares, Mario R. A. da Silva, Daniel M. F. Palhares, Ben-Hur F. Neto, Fabio M. do R. Barros, Roberto de A. Gil, Aline Chagas & Flair José Carrilho. (2020) Epidemiological and Clinical Patterns of Newly Diagnosed Hepatocellular Carcinoma in Brazil: the Need for Liver Disease Screening Programs Based on Real-World Data. Journal of Gastrointestinal Cancer 52:3, pages 952-958.
Crossref
Crossref
Huajie Cai, Yihu Zheng, Zhengde Wen, Yingnan Yang, Shouzhang Yang & Qiyu Zhang. (2021) LncRNA AIRN influences the proliferation and apoptosis of hepatocellular carcinoma cells by regulating STAT1 ubiquitination. Archives of Pharmacal Research 44:4, pages 414-426.
Crossref
Crossref
Mihajlo Djokic, Maja Cemazar, Masa Bosnjak, Rok Dezman, David Badovinac, Damijan Miklavcic, Bor Kos, Miha Stabuc, Borut Stabuc, Rado Jansa, Peter Popovic, Lojze M. Smid, Gregor Sersa & Blaz Trotovsek. (2020) A Prospective Phase II Study Evaluating Intraoperative Electrochemotherapy of Hepatocellular Carcinoma. Cancers 12:12, pages 3778.
Crossref
Crossref
Caroline O’Keefe-Markman, Kristina Dawn Lea, Christopher McCabe, Elaine Hyshka & Tania Bubela. (2020) Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment. BMC Public Health 20:1.
Crossref
Crossref
Jingyu Zhao, Xinyue Zhang, Liwei Fang, Hong Pan & Jun Shi. (2020) Association between IL28B Polymorphisms and Outcomes of Hepatitis B Virus Infection: A meta-analysis. BMC Medical Genetics 21:1.
Crossref
Crossref
Raphael Iglesias de Oliveira Vidal, Edison Iglesias de Oliveira Vidal, Basilio de Bragança Pereira, Cachimo Combo Assane, Alexandre Ribeiro, Emilia Matos do Nascimento, Fernando Gomes Romeiro & Joaquim Ribeiro Filho. (2020) Risk Factors for Hepatocellular Carcinoma Recurrence and Survival after Liver Transplantation in Patients with HCV-Related Cirrhosis. BioMed Research International 2020, pages 1-8.
Crossref
Crossref
Snehal S. Patel, Richa Tripathi, Vishal K. Chavda & Jignasa K. Savjani. (2020) Anticancer Potential of Mefenamic Acid Derivatives with Platelet-Derived Growth Factor Inhibitory Property. Anti-Cancer Agents in Medicinal Chemistry 20:8, pages 998-1008.
Crossref
Crossref
Kadir TomasSukru OguzSerdar TopalogluAdnan CalikMehmet ArslanHasan DinçFeyyaz OzdemirHakan KucukaslanUmit CobanogluErdem Karabulut & Mehmet Halil ÖZtÜRk. (2020) Is it Rational to Perform Liver Resection for Patients with Intermediate and Advanced Stages of Hepatocellular Carcinoma?. The American Surgeon 86:4, pages 313-323.
Crossref
Crossref
Belonwu Onyenekwe & Uche Unigwe. (2020) Hepatocellular carcinoma with initial presentation as metastatic spinal cord compression. NIGERIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 12:1, pages 24.
Crossref
Crossref
Kwok-Chui Cheng, Chau-Jong Wang, Yun-Ching Chang, Tung-Wei Hung, Chun-Jung Lai, Chi-Wen Kuo & Hui-Pei Huang. (2020) Mulberry fruits extracts induce apoptosis and autophagy of liver cancer cell and prevent hepatocarcinogenesis in vivo. Journal of Food and Drug Analysis 28:1, pages 84-93.
Crossref
Crossref
Jianhua Li, Wenzhi Guo, Wenping Xue, Pengfei Xu, Zhen Deng, Danhua Zhang, Shouhua Zheng & Xinguang Qiu. (2019) Long noncoding RNA AURKAPS1 potentiates malignant hepatocellular carcinoma progression by regulating miR-142, miR-155 and miR-182. Scientific Reports 9:1.
Crossref
Crossref
Zhaoyu Qin, Chan Xiang, Fan Zhong, Yang Liu, Qiongzhu Dong, Kai Li, Wenhao Shi, Chen Ding, Lunxiu Qin & Fuchu He. (2019) Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
Doris Kaltenecker, Madeleine Themanns, Kristina M. Mueller, Katrin Spirk, Nicole Golob-Schwarzl, Katrin Friedbichler, Lukas Kenner, Johannes Haybaeck & Richard Moriggl. (2019) STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. Cytokine 124, pages 154573.
Crossref
Crossref
Xiaotong Su, Jutong Su, Hua He, Yong Zhan & Haichao Liu. (2019) Hsa_circ_0070269 inhibits hepatocellular carcinoma progression through modulating miR-182/NPTX1 axis. Biomedicine & Pharmacotherapy 120, pages 109497.
Crossref
Crossref
Mohamed A. Nasr, Radwa Ayman Salah, M. Abd Elkodous, Shimaa E. Elshenawy & Nagwa El-Badri. (2019) Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells. Frontiers in Cell and Developmental Biology 7.
Crossref
Crossref
Yu Jin, Ye Shen Wong, Brian K. P. Goh, Chung Yip Chan, Peng Chung Cheow, Pierce K. H. Chow, Tony K. H. Lim, George B. B. Goh, Thinesh Lee Krishnamoorthy, Rajneesh Kumar, Tze Pin Ng, Samuel S. Chong, Hwee Huang Tan, Alexander Y. F. Chung, London Lucien P. J. Ooi, Jason P. E. Chang, Chee Kiat Tan & Caroline G. L. Lee. (2019) Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma. Scientific Reports 9:1.
Crossref
Crossref
Sarah S. Dinges, Annika Hohm, Lindsey A. Vandergrift, Johannes Nowak, Piet Habbel, Igor A. Kaltashov & Leo L. Cheng. (2019) Cancer metabolomic markers in urine: evidence, techniques and recommendations. Nature Reviews Urology 16:6, pages 339-362.
Crossref
Crossref
Hao Xing, Haibo Qiu, Xuemei Ding, Jun Han, Zhenli Li, Han Wu, Cunling Yan, Huijun Li, Ruilin Han, Han Zhang, Chao Li, Mingda Wang, Mengchao Wu, Feng Shen, Yijie Zheng & Tian Yang. (2019) Clinical performance of α-L-fucosidase for early detection of hepatocellular carcinoma. Biomarkers in Medicine 13:7, pages 545-555.
Crossref
Crossref
Qian Li, Xin-Pei Liu, Duo-Wei Wang, Yi-Ming Shen, Qiang Jia & Wen-Tian Liu. (2019)
Brachytherapy using elastin-like polypeptide with different concentrations of
131
I for treatment of VX2 liver tumor in rabbits
. World Chinese Journal of Digestology 27:8, pages 485-493.
Crossref
Crossref
Vivek K. Chaturvedi, Anshuman Singh, Sushil K. Dubey, Helal F. Hetta, James John & M.P. Singh. (2019) Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma. Microbial Pathogenesis 128, pages 184-194.
Crossref
Crossref
Dhatri Madduru, Johny Ijaq, Sujata Dhar, Saumyadip Sarkar, Naresh Poondla, Partha S. Das, Silvia Vasquez & Prashanth Suravajhala. (2019) Systems Challenges of Hepatic Carcinomas: A Review. Journal of Clinical and Experimental Hepatology 9:2, pages 233-244.
Crossref
Crossref
Elaine Holmes, Ian D. Wilson & John C. Lindon. 2019. The Handbook of Metabolic Phenotyping. The Handbook of Metabolic Phenotyping
1
51
.
Jennifer Y. Chen, Dhruv Thakar & Tammy T. Chang. 2019. Fibrosis in Disease. Fibrosis in Disease
387
417
.
Hinako Kimura, Naoya Matsunaga, Keisuke Kakimoto, Miyako Watanabe, Akito Tsuruta, Naoki Kusunose, Shoya Shiromizu, Satoru Koyanagi & Shigehiro Ohdo. (2018) Epithelial cell adhesion molecule expression in hepatic stem/progenitor cells is controlled by the molecular clock system. Biochemical and Biophysical Research Communications 503:2, pages 1063-1069.
Crossref
Crossref
Yang Sun, Jieli Luo, Jianshe Chen, Fangting Xu, Xinfa Ding & Pintong Huang. (2018) Ultrasound-mediated microbubbles destruction for treatment of rabbit VX2 orthotopic hepatic tumors. Applied Acoustics 138, pages 216-225.
Crossref
Crossref
Eunjeong Kim, Donghyo Kim, Jeon‐Soo Lee, Jeehyun Yoe, Jongmin Park, Chang‐Jin Kim, Dongjun Jeong, Sanguk Kim & Yoontae Lee. (2018) Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4–MMP1 axis. Hepatology 67:6, pages 2287-2301.
Crossref
Crossref
Natalia Freitas, Tetyana Lukash, Sumedha Gunewardena, Benjamin Chappell, Betty L. Slagle & Severin O. Gudima. (2018) Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers. Journal of Virology 92:10.
Crossref
Crossref
Jing Hu, Jingli Hu, Hongmei Jiao & Qingguo Li. (2018) Anesthetic effects of isoflurane and the molecular mechanism underlying isoflurane‑inhibited aggressiveness of hepatic carcinoma. Molecular Medicine Reports.
Crossref
Crossref
A. W. Singer, K. R. Reddy, L. E. Telep, A. O. Osinusi, D. M. Brainard, M. Buti & A. P. Chokkalingam. (2018) Direct-acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study. Alimentary Pharmacology & Therapeutics 47:9, pages 1278-1287.
Crossref
Crossref
Mihajlo Djokic, Maja Cemazar, Peter Popovic, Bor Kos, Rok Dezman, Masa Bosnjak, Martina Niksic Zakelj, Damijan Miklavcic, Stojan Potrc, Borut Stabuc, Ales Tomazic, Gregor Sersa & Blaz Trotovsek. (2018) Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study. European Journal of Surgical Oncology 44:5, pages 651-657.
Crossref
Crossref
Lei Gu, Wen Wen, ZhiXian Wu, Kai Bai, Wei Liu, GuoXiang Lai & DongLiang Li. (2018) Abnormal platelet count correlates with poor survival in hepatocellular carcinoma. Infection International 6:3, pages 93-102.
Crossref
Crossref
Lin Wang, Chen Chen, Shuzhi Feng & Jianli Tian. (2018) TIPE‑2 suppresses growth and aggressiveness of hepatocellular carcinoma cells through downregulation of the phosphoinositide 3‑kinase/AKT signaling pathway. Molecular Medicine Reports.
Crossref
Crossref
Janio Szklaruk, Diana Kaya & Wei Wei. (2018) Evaluation of the added value of imaging the pelvis in patients with hepatocellular cancer. Journal of Gastroenterology and Hepatology 33:2, pages 500-502.
Crossref
Crossref
Yan Ma, Yanfang Chen, Lei Chen, Zhi Liu, Mio-Leng Ieong, Fei Gao & Wei Huang. (2018) Promotion of Insulin-like growth factor II in cell proliferation and epithelial–mesenchymal transition in hepatocellular carcinoma. Journal of Cancer Research and Therapeutics 14:4, pages 844-850.
Crossref
Crossref
Mohab H. Halim, Nour A. Abdulla, Abdelkarim Kamel, Nabila Abd El Maksoud & Halla M. Ragab. (2017) Significance of growth differentiation factor 15 in chronic HCV patients. Journal of Genetic Engineering and Biotechnology 15:2, pages 403-407.
Crossref
Crossref
Ahmed Ebraheem Ebeed, Marwa Abd El-hamied Romeih, Medhat Mohamed Refat & Mohamed Hamdy Yossef. (2017) Role of dynamic contrast-enhanced and diffusion weighted MRI in evaluation of hepatocellular carcinoma after chemoembolization. The Egyptian Journal of Radiology and Nuclear Medicine 48:4, pages 807-815.
Crossref
Crossref
Yuxia Wang, Xiangxiang Gu, Hongmei Deng, Di Geng, Huaying Sun & Chunmei Wang. (2017) Anti-tumor activities of macromolecular fractions of fresh gecko in vivo and their induction of Bel-7402 cell differentiation. Journal of Traditional Chinese Medical Sciences 4:4, pages 328-335.
Crossref
Crossref
Yan Fu, Xiao Xu, Dongsheng Huang, Dawei Cui, Lisheng Liu, Junwei Liu, Zenglei He, Jingjing Liu, Shusen Zheng & Yongzhang Luo. (2017) Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: An Official, Large-scale, and Multicenter Clinical Trial. EBioMedicine 24, pages 56-63.
Crossref
Crossref
Chi Pang, Gang Huang, Kaili Luo, Yuying Dong, Fengtian He, Guankui Du, Man Xiao & Wangwei Cai. (2017) miR-206 inhibits the growth of hepatocellular carcinoma cells via targeting CDK9. Cancer Medicine 6:10, pages 2398-2409.
Crossref
Crossref
Jie Liu, Guo-Zheng Yu, Xiao-Ke Cheng, Xiao-Dong Li, Xian-Tao Zeng & Xue-Qun Ren. (2017) LGR5 promotes hepatocellular carcinoma metastasis through inducting epithelial-mesenchymal transition. Oncotarget 8:31, pages 50896-50903.
Crossref
Crossref
George Boon‐Bee Goh, James Weiquan Li, Pik‐Eu Chang, Khuan‐Yew Chow & Chee‐Kiat Tan. (2017) Deciphering the epidemiology of hepatocellular carcinoma through the passage of time: A study of 1,401 patients across 3 decades. Hepatology Communications 1:6, pages 564-571.
Crossref
Crossref
Trieu-My Van, Apostolos Polykratis, Beate Katharina Straub, Vangelis Kondylis, Nikoletta Papadopoulou & Manolis Pasparakis. (2017) Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis. Journal of Clinical Investigation 127:7, pages 2662-2677.
Crossref
Crossref
Li-Na Ma, Xiao-Yan Liu, Zhen-Hui Lu, Li-Gang Wu, Yuan-Yuan Tang, Xia Luo, Yan-Chao Hu, Ting-Ting Yan, Qi Wang, Xiang-Chun Ding & Yan Xie. (2017) Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis. Oncology Letters 13:5, pages 3457-3464.
Crossref
Crossref
Meng-Yu Zhang & Jie-Ping Wang. (2017) A multi-target protein of hTERTR-FAM96A presents significant anticancer potent in the treatment of hepatocellular carcinoma. Tumor Biology 39:4, pages 101042831769834.
Crossref
Crossref
Rejina Afrin, Somasundaram Arumugam, Azizur Rahman, Mir Imam Ibne Wahed, Vengadeshprabhu Karuppagounder, Meilei Harima, Hiroshi Suzuki, Shizuka Miyashita, Kenji Suzuki, Hiroyuki Yoneyama, Kazuyuki Ueno & Kenichi Watanabe. (2017) Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation. International Immunopharmacology 44, pages 174-182.
Crossref
Crossref
An-Ting Liou, Mei-Fang Chen & Chu-Wen Yang. (2017) Curcumin Induces p53-Null Hepatoma Cell Line Hep3B Apoptosis through the AKT-PTEN-FOXO4 Pathway. Evidence-Based Complementary and Alternative Medicine 2017, pages 1-12.
Crossref
Crossref
Maria Helena Oliveira. 2017. Cytopathology. Cytopathology
197
200
.
Blaž Trotovšek & Mihajlo Đokić. 2017. Handbook of Electroporation. Handbook of Electroporation
1855
1870
.
Thirupathi Anand, Ayu Muthia & Shanmugavadivelu Chandra Mo. (2016) Ethanolic Extract of Canthium coromandelicum Leaves Exhibits Antioxidant, Anti-inflammatory and Apoptotic Activity in DEN-induced Hepatocellular Carcinoma. Research Journal of Phytochemistry 11:1, pages 1-10.
Crossref
Crossref
Dian-Gang Liu, Jing Chen, Hong-Xia Wang & Bao-Xin Li. (2016) Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma. Oncology Letters 12:6, pages 4961-4968.
Crossref
Crossref
Sofia Vitor, Rui Tato Marinho, José Gíria & José Velosa. (2016) An observational study of the direct costs related to hospital admissions, mortality and premature death associated with liver disease in Portugal. BMC Research Notes 9:1.
Crossref
Crossref
Bo Tang, Biao Lei, Guangying Qi, Xingsi Liang, Fang Tang, Shengguang Yuan, Zhenran Wang, Shuiping Yu & Songqing He. (2016) MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression. Journal of Experimental & Clinical Cancer Research 35:1.
Crossref
Crossref
Sabrina Bimonte, Maddalena Leongito, Mauro Piccirillo, Cristina de Angelis, Claudia Pivonello, Vincenza Granata & Francesco Izzo. (2016) Radio-frequency ablation-based studies on VX2rabbit models for HCC treatment. Infectious Agents and Cancer 11:1.
Crossref
Crossref
E-Na Qian, Shuang-Yin Han, Song-Ze Ding & Xun Lv. (2016) Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinoma. Cancer Cell International 16:1.
Crossref
Crossref
John Carson Allen, Jean-Charles Nault, Guili Zhu, Andrew Yu Keat Khor, Jin Liu, Tony Kiat Hon Lim, Jessica Zucman-Rossi & Pierce K.H. Chow. (2016) The transcriptomic G1–G6 signature of hepatocellular carcinoma in an Asian population. Medicine 95:47, pages e5263.
Crossref
Crossref
Meng Xu, Qingquan Liu, Yuli Jia, Kangsheng Tu, Yingmin Yao, Qingguang Liu & Cheng Guo. (2016) BCAT1 promotes tumor cell migration and invasion in hepatocellular carcinoma. Oncology Letters 12:4, pages 2648-2656.
Crossref
Crossref
Mònica Pons, Macarena Simón-Talero, Laura Millán, Meritxell Ventura-Cots, Begoña Santos, Salvador Augustin & Joan Genescà. (2016) Basal values and changes of liver stiffness predict the risk of disease progression in compensated advanced chronic liver disease. Digestive and Liver Disease 48:10, pages 1214-1219.
Crossref
Crossref
Abdelfattah M. Attallah, Mohamed El-Far, Mohamed M. Omran, Mohamed A. Abdelrazek, Ahmed A. Attallah, Aya M. Saeed & Khaled Farid. (2016) GPC-HCC model: a combination of glybican-3 with other routine parameters improves the diagnostic efficacy in hepatocellular carcinoma. Tumor Biology 37:9, pages 12571-12577.
Crossref
Crossref
A V Tkachev, G N Tarasova, V S Groshilin, D A Vasilchenkov, T I Ushakova & D V Blinov. (2016) Prevalence of nonalcoholic fatty liver disease in outpatients in Rostov-on-Don: Regional results of the DIREG-2 study. Terapevticheskii arkhiv 88:8, pages 59-66.
Crossref
Crossref
M. Donat, S. Alonso, F. Pereira, E. Ferrero, L. Carrión, D. Acin-Gándara & E. Moreno. (2016) Impact of Histological Factors of Hepatocellular Carcinoma on the Outcome of Liver Transplantation. Transplantation Proceedings 48:6, pages 1968-1977.
Crossref
Crossref
Miral Sadaria Grandhi, Amy K. Kim, Sean M. Ronnekleiv-Kelly, Ihab R. Kamel, Mounes A. Ghasebeh & Timothy M. Pawlik. (2016) Hepatocellular carcinoma: From diagnosis to treatment. Surgical Oncology 25:2, pages 74-85.
Crossref
Crossref
Ahmed Abdel-Razik, Rania Elhelaly, Rasha Elzehery, Amany El-Diasty, Sally Abed, Dina Elhammady & Ahmed Tawfik. (2016) Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study. European Journal of Gastroenterology & Hepatology 28:5, pages 599-605.
Crossref
Crossref
Xiuhong Liu, Shuang Wang, Xianghua Guo, Feili Wei, Jiming Yin, Yunjin Zang, Ning Li & Dexi Chen. (2016) Exogenous p53 and ASPP2 expression enhances rAdV-TK/GCV-induced death in hepatocellular carcinoma cells lacking functional p53. Oncotarget 7:14, pages 18896-18905.
Crossref
Crossref
XUE-QIN MENG, WEI ZHANG, FENG ZHANG, SHENG-YONG YIN, HAI-YANG XIE, LIN ZHOU & SHU-SEN ZHENG. (2016) Solanine-induced reactive oxygen species inhibit the growth of human hepatocellular carcinoma HepG2 cells. Oncology Letters 11:3, pages 2145-2151.
Crossref
Crossref
Jhen-Yu Chen, Yun-Ju Chen, Chia-Jui Yen, Wen-Shu Chen & Wei-Chien Huang. (2015) HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3. Oncotarget 7:1, pages 473-489.
Crossref
Crossref
LI-SHUAI QU, FEI JIN, YAN-MEI GUO, TAO-TAO LIU, RU-YI XUE, XIAO-WU HUANG, MIN XU, TAO-YANG CHEN, ZHENG-PING NI & XI-ZHONG SHEN. (2016) Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study. Oncology Letters 11:1, pages 624-632.
Crossref
Crossref
Abdulrahman A. Aljumah, Hadi Kuriry, Mohammed AlZunaitan, Mohammed Al Ghobain, Mohamed Al Muaikeel, Ashwaq Al Olayan, Fahad Azzumeea, Bader Almutairi, Abduljaleel AlAlwan & Hamdan AlGhamdi. (2016) Clinical Presentation, Risk Factors, and Treatment Modalities of Hepatocellular Carcinoma: A Single Tertiary Care Center Experience. Gastroenterology Research and Practice 2016, pages 1-9.
Crossref
Crossref
Blaž Trotovšek & Mihajlo Đokić. 2016. Handbook of Electroporation. Handbook of Electroporation
1
16
.
Zongguo Yang, Jianliang Zhang, Yunfei Lu, Qingnian Xu, Bozong Tang, Qiang Wang, Wensi Zhang, Shishi Chen, Lingqing Lu & Xiaorong Chen. (2015) Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization. Oncotarget 6:40, pages 43090-43098.
Crossref
Crossref
Daizhong Liu, Aixiang Liu, Junping Peng, Yong Hu & Xielin Feng. (2015) Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib. European Journal of Medical Research 20:1.
Crossref
Crossref
Weining Wang, N. Gopalakrishna Iyer, Hsien Ts’ung Tay, Yonghui Wu, Tony K. H. Lim, Lin Zheng, In Chin Song, Chee Keong Kwoh, Hung Huynh, Patrick O. B. Tan & Pierce K. H. Chow. (2015) Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma. BMC Cancer 15:1.
Crossref
Crossref
Wendy Wing Tak Lam, Qiuyan Liao, Jennifer Hiu Fai Wong, Ching Lung Lai, Man Fung Yuen, Janice Wing Hang Tsang & Richard Fielding. (2015) Measuring and Validating a General Cancer Predisposition Perception Scale: An Adaptation of the Revised-IPQ-Genetic Predisposition Scale. PLOS ONE 10:11, pages e0142620.
Crossref
Crossref
M.I. Sánchez-Lorencio, P. Ramirez, L. Saenz, M.V. Martínez Sánchez, V. De La Orden, B. Mediero-Valeros, S. Veganzones-De-Castro, A. Baroja-Mazo, B. Revilla Nuin, M.R. Gonzalez, P.A. Cascales-Campos, J.A. Noguera-Velasco, A. Minguela, E. Díaz-Rubio, J.A. Pons & P. Parrilla. (2015) Comparison of Two Types of Liquid Biopsies in Patients With Hepatocellular Carcinoma Awaiting Orthotopic Liver Transplantation. Transplantation Proceedings 47:9, pages 2639-2642.
Crossref
Crossref
Vangelis Kondylis, Apostolos Polykratis, Hanno Ehlken, Laura Ochoa-Callejero, Beate Katharina Straub, Santosh Krishna-Subramanian, Trieu-My Van, Harald-Morten Curth, Nicole Heise, Falk Weih, Ulf Klein, Peter Schirmacher, Michelle Kelliher & Manolis Pasparakis. (2015) NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis. Cancer Cell 28:5, pages 582-598.
Crossref
Crossref
Pingbo Xu, Zhirong Sun, Yun wang & Changhong Miao. (2015) Long-term use of indomethacin leads to poor prognoses through promoting the expression of PD-1 and PD-L2 via TRIF/NF-κB pathway and JAK/STAT3 pathway to inhibit TNF-α and IFN-γ in hepatocellular carcinoma. Experimental Cell Research 337:1, pages 53-60.
Crossref
Crossref
Mariana V. Machado & Helena Cortez-Pinto. (2015) Proangiogenic factors in the development of HCC in alcoholic cirrhosis. Clinics and Research in Hepatology and Gastroenterology 39, pages S104-S108.
Crossref
Crossref
San-Qiang Li, Zhi-Hong Hu, Sha Zhu, Dong-Mei Wang, Hong-Mei Han & Hua-Jie Lu. (2015) The Effect of ADAM8 on the Proliferation and Apoptosis of Hepatocytes and Hepatoma Carcinoma Cells. Journal of Biochemical and Molecular Toxicology 29:9, pages 440-448.
Crossref
Crossref
Elaine Holmes, Anisha Wijeyesekera, Simon D. Taylor-Robinson & Jeremy K. Nicholson. (2015) The promise of metabolic phenotyping in gastroenterology and hepatology. Nature Reviews Gastroenterology & Hepatology 12:8, pages 458-471.
Crossref
Crossref
Qibin Liao, Peiyu Han, Yue Huang, Zhitong Wu, Qing Chen, Shanshan Li, Jufeng Ye & Xianbo Wu. (2015) Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis. PLOS ONE 10:6, pages e0130677.
Crossref
Crossref
Xiuying Liu, Xiumei Chi, Qiaoling Gong, Lei Gao, Yuqiang Niu, Xiaojing Chi, Min Cheng, Youhui Si, Maorong Wang, Jin Zhong, Junqi Niu & Wei Yang. (2015) Association of Serum Level of Growth Differentiation Factor 15 with Liver Cirrhosis and Hepatocellular Carcinoma. PLOS ONE 10:5, pages e0127518.
Crossref
Crossref
Morten A. KarsdalTina Manon-JensenFederica GenoveseJacob H. KristensenMette J. NielsenJannie Marie B. SandNiels-Ulrik B. HansenAnne-Christine Bay-JensenCecilie L. BagerAleksander KragAndy BlanchardHenrik KrarupDiana J. LeemingDetlef Schuppan. (2015) Novel insights into the function and dynamics of extracellular matrix in liver fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology 308:10, pages G807-G830.
Crossref
Crossref
Simon D Taylor-Robinson, Jessica Wong, Mary M E Crossey & Shahid A Khan. (2015) Evidence is weak to support hepatocellular carcinoma screening in chronic liver disease. Evidence Based Medicine 20:2, pages 59-59.
Crossref
Crossref
Monique R. Bernsen, Klazina Kooiman, Marcel Segbers, Fijs W. B. van Leeuwen & Marion de Jong. (2015) Biomarkers in preclinical cancer imaging. European Journal of Nuclear Medicine and Molecular Imaging 42:4, pages 579-596.
Crossref
Crossref
Masaaki Kondo, Manabu Morimoto, Tomohiro Ishii, Akito Nozaki, Hiroyuki Fukuda, Kazushi Numata, Satoshi Kobayashi, Shinichi Ohkawa, Hisashi Hidaka, Takahide Nakazawa, Akitaka Shibuya, Chiaki Okuse, Michihiro Suzuki, Kentaro Sakamaki, Satoshi Morita, Shin Maeda & Katsuaki Tanaka. (2015) Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score-based weighting. Journal of Digestive Diseases 16:3, pages 143-151.
Crossref
Crossref
Wanyuan Bao, Feng Zhu, Yunfei Duan, Yue Yang & Huihua Cai. (2015) HtrA1 resensitizes multidrug-resistant hepatocellular carcinoma cells by targeting XIAP. Biomedicine & Pharmacotherapy 70, pages 97-102.
Crossref
Crossref
Xuehong Chen, Yantao Han, Songmei Zhan, Chunbo Wang & Shouguo Chen. (2014) Tegillarca granosa Extract Haishengsu Induces Apoptosis in Human Hepatocellular Carcinoma Cell Line BEL-7402 Via Fas-Signaling Pathways. Cell Biochemistry and Biophysics 71:2, pages 837-844.
Crossref
Crossref
Francesca M Trovato. (2015) Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers. World Journal of Hepatology 7:26, pages 2664.
Crossref
Crossref
Song-Zhu Yang. (2015)
Downregulation of
KIF1B
mRNA in hepatocellular carcinoma tissues correlates with poor prognosis
. World Journal of Gastroenterology 21:27, pages 8418.
Crossref
Crossref
Ke-Zhu Hou. (2015)
Chemokine ligand 20 enhances progression of hepatocellular carcinoma
via
epithelial-mesenchymal transition
. World Journal of Gastroenterology 21:2, pages 475.
Crossref
Crossref
Wei Huang. (2015) Decaprenyl diphosphate synthase subunit 2 as a prognosis factor in hepatocellular carcinoma. World Journal of Gastroenterology 21:10, pages 3055.
Crossref
Crossref
Myung-Won YouSo Yeon KimKyoung Won KimSo Jung LeeYong Moon ShinJin Hee KimMoon-Gyu Lee. (2015) Recent advances in the imaging of hepatocellular carcinoma. Clinical and Molecular Hepatology 21:1, pages 95.
Crossref
Crossref
Mingyue Zhu, Bo Lin, Peng Zhou & Mengsen Li. (2015) Molecular Analysis of AFP and HSA Interactions with PTEN Protein. BioMed Research International 2015, pages 1-7.
Crossref
Crossref
Pei-Pei Li, Wei He, Ping-Fan Yuan, Sha-Sha Song, Jing-Tao Lu & Wei Wei. (2015) Celastrol Induces Mitochondria-Mediated Apoptosis in Hepatocellular Carcinoma Bel-7402 Cells. The American Journal of Chinese Medicine 43:01, pages 137-148.
Crossref
Crossref
Kelly J. Lafaro, Aram N. Demirjian & Timothy M. Pawlik. (2015) Epidemiology of Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 24:1, pages 1-17.
Crossref
Crossref
Huan Zhou, Minying Xu, Ya Gao, Zhigang Deng, Hanwei Cao, Wenqing Zhang, Qiao Wang, Bing Zhang, Gang Song, Yanyan Zhan & Tianhui Hu. (2014) Matrine induces caspase-independent program cell death in hepatocellular carcinoma through bid-mediated nuclear translocation of apoptosis inducing factor. Molecular Cancer 13:1.
Crossref
Crossref
Fang Liu, Changlai Zhu, Xiaodong Huang, Jing Cai, Hua Wang, Xinxiu Wang, Song He, Cheng Liu, Xiaojing Yang, Yixin Zhang & Tianyi Zhang. (2014) A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival. Pathology - Research and Practice 210:12, pages 885-892.
Crossref
Crossref
Zhiming Xiang, Qianwen Liang, Changhong Liang & Guimian Zhong. (2014) The Correlation of Contrast-Enhanced Ultrasound and MRI Perfusion Quantitative Analysis in Rabbit VX2 Liver Cancer. Cell Biochemistry and Biophysics 70:3, pages 1859-1867.
Crossref
Crossref
Shibo Qi, Bin Li, Tan Yang, Yong Liu, Shanshan Cao, Xingxing He, Peng Zhang, Lei Li & Chuanrui Xu. (2014) Validation of Bmi1 as a Therapeutic Target of Hepatocellular Carcinoma in Mice. International Journal of Molecular Sciences 15:11, pages 20004-20021.
Crossref
Crossref
QIURAN XU, XIN LIU, XIN ZHENG, YINGMIN YAO & QINGGUANG LIU. (2014) PKM2 regulates Gli1 expression in hepatocellular carcinoma. Oncology Letters 8:5, pages 1973-1979.
Crossref
Crossref
H Ehlken, S Krishna-Subramanian, L Ochoa-Callejero, V Kondylis, N E Nadi, B K Straub, P Schirmacher, H Walczak, G Kollias & M Pasparakis. (2014) Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout. Cell Death & Differentiation 21:11, pages 1721-1732.
Crossref
Crossref
TingTing Qi, JinFeng Liao, YiSong Li, JinRong Peng, WenTing Li, BingYang Chu, He Li, YuQuan Wei & ZhiYong Qian. (2014) Label-free alpha fetoprotein immunosensor established by the facile synthesis of a palladium–graphene nanocomposite. Biosensors and Bioelectronics 61, pages 245-250.
Crossref
Crossref
M Chiu, S Tardito, S Pillozzi, A Arcangeli, A Armento, J Uggeri, G Missale, M G Bianchi, A Barilli, V Dall'Asta, N Campanini, E M Silini, J Fuchs, S Armeanu-Ebinger & O Bussolati. (2014) Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts. British Journal of Cancer 111:6, pages 1159-1167.
Crossref
Crossref
Haiqing Wang, Jian Yang, Jiayin Yang, Li Jiang, Tianfu Wen, Wentao Wang, Mingqing Xu, Bo Li & Lunan Yan. (2014) Development and Validation of a Prediction Score for Complications after Hepatectomy in Hepatitis B-Related Hepatocellular Carcinoma Patients. PLoS ONE 9:8, pages e105114.
Crossref
Crossref
Jie Chao, Xiao-Fei Zhang, Qiu-Zhong Pan, Jing-Jing Zhao, Shan-Shan Jiang, Ying Wang, Jian-Hua Zhang & Jian-Chuan Xia. (2014) Decreased expression of TRIM3 is associated with poor prognosis in patients with primary hepatocellular carcinoma. Medical Oncology 31:8.
Crossref
Crossref
Xuqi Li, Pei Li, Yuanhong Chang, Qinhong Xu, Zheng Wu, Qingyong Ma & Zheng Wang. (2014) The SDF-1/CXCR4 axis induces epithelial–mesenchymal transition in hepatocellular carcinoma. Molecular and Cellular Biochemistry 392:1-2, pages 77-84.
Crossref
Crossref
Haiqing Wang, Jian Yang, Xiaowu Zhang, Lunan Yan & Jiayin Yang. (2014) Liver Resection in Hepatitis B-Related Hepatocellular Carcinoma: Clinical Outcomes and Safety in Overweight and Obese Patients. PLoS ONE 9:6, pages e99281.
Crossref
Crossref
Jianhui Zhu, Zhenxin Lin, Jing Wu, Haidi Yin, Jianliang Dai, Ziding Feng, Jorge Marrero & David M. Lubman. (2014) Analysis of Serum Haptoglobin Fucosylation in Hepatocellular Carcinoma and Liver Cirrhosis of Different Etiologies. Journal of Proteome Research 13:6, pages 2986-2997.
Crossref
Crossref
Daniela Valletta, Barbara Czech, Thilo Spruss, Kristian Ikenberg, Peter Wild, Arndt Hartmann, Thomas S. Weiss, Peter J. Oefner, Martina Müller, Anja-Katrin Bosserhoff & Claus Hellerbrand. (2014) Regulation and function of the atypical cadherin FAT1 in hepatocellular carcinoma. Carcinogenesis 35:6, pages 1407-1415.
Crossref
Crossref
Felipe A. Castro, Xiangdong Liu, Asta Försti, Jianguang Ji, Jan Sundquist, Kristina Sundquist, Jill Koshiol & Kari Hemminki. (2014) Increased Risk of Hepatobiliary Cancers After Hospitalization for Autoimmune Disease. Clinical Gastroenterology and Hepatology 12:6, pages 1038-1045.e7.
Crossref
Crossref
Liang Shi, Li-Li Wu, Jian-Rong Yang, Xiao-Fei Chen, Yi Zhang, Zeng-Qiang Chen, Cun-Li Liu, Sheng-Ying Chi, Jia-Ying Zheng, Hai-Xia Huang, Fu-Jun Yu & Xiang-Yang Lin. (2014) Serum Peroxiredoxin3 is a Useful Biomarker for Early Diagnosis and Assessemnt of Prognosis of Hepatocellular Carcinoma in Chinese Patients. Asian Pacific Journal of Cancer Prevention 15:7, pages 2979-2986.
Crossref
Crossref
Wen Xia Li, Zhao Li, Peng Ji Gao, Jie Gao & Ji Ye Zhu. (2014) Histological differentiation predicts post-liver transplantation survival time. Clinics and Research in Hepatology and Gastroenterology 38:2, pages 201-208.
Crossref
Crossref
Yun-Qing Qiu, Jue Zhou, Xin-Shan Kang, Lie-Ming Ding, Wei Yu, Fen-Lai Tan & Dan-Feng Deng. (2014) Effect of BZG-4000, a novel multi-targeted kinase inhibitor with potent anticancer activity, on a hepatocellular carcinoma xenograft model. Scientific Reports 4:1.
Crossref
Crossref
Nan-Ya Wang, Cong Wang, Wei Li, Guan-Jun Wang, Guo-Zhen Cui, Hua He & Heng-Jun Zhao. (2014) Prognostic Value of Serum AFP, AFP-L3, and GP73 in Monitoring Short-term Treatment Response and Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation. Asian Pacific Journal of Cancer Prevention 15:4, pages 1539-1544.
Crossref
Crossref
Peixin Huang, Xiaojing Xu, Lingyan Wang, Bijun Zhu, Xiangdong Wang & Jingling Xia. (2013)
The role of
EGF
‐
EGFR
signalling pathway in hepatocellular carcinoma inflammatory microenvironment
. Journal of Cellular and Molecular Medicine 18:2, pages 218-230.
Crossref
Crossref
Dimitrios N Samonakis. (2014) Clinical outcome of compensated and decompensated cirrhosis: A long term study. World Journal of Hepatology 6:7, pages 504.
Crossref
Crossref
Nimzing G Ladep. (2014) Problem of hepatocellular carcinoma in West Africa. World Journal of Hepatology 6:11, pages 783.
Crossref
Crossref
Hai-Qing Wang. (2014) Low immediate postoperative platelet count is associated with hepatic insufficiency after hepatectomy. World Journal of Gastroenterology 20:33, pages 11871.
Crossref
Crossref
Yasunobu Matsuda, Toshifumi Wakai, Masayuki Kubota, Masaaki Takamura, Satoshi Yamagiwa, Yutaka Aoyagi, Mami Osawa, Shun Fujimaki, Ayumi Sanpei, Takuya Genda & Takafumi Ichida. (2013) Clinical significance of cell cycle inhibitors in hepatocellular carcinoma. Medical Molecular Morphology 46:4, pages 185-192.
Crossref
Crossref
Bin Sun, Xiaofeng Zhang, Xianshuo Cheng, Yu Zhang, Lei Chen, Lehua Shi, Zhenyu Liu, Haihua Qian, Mengchao Wu & Zhengfeng Yin. (2013) Intratumoral Hepatic Stellate Cells as a Poor Prognostic Marker and a New Treatment Target for Hepatocellular Carcinoma. PLoS ONE 8:11, pages e80212.
Crossref
Crossref
Shi-Gang Shan, Ying-Tang Gao, Yan-Jie Xu, Yong Huang, Qin Zhang, Dao-Kuan Zhai, Jian-Biao Li, Feng-Mei Wang, Xiang Jing, Zhi Du & Yi-Jun Wang. (2013) Gradually increased Golgi protein 73 expression in the progression of benign liver diseases to precancerous lesions and hepatocellular carcinoma correlates with prognosis of patients. Hepatology Research 43:11, pages 1199-1210.
Crossref
Crossref
Shingo Tanaka, Koji Miyanishi, Masayoshi Kobune, Yutaka Kawano, Toshifumi Hoki, Tomohiro Kubo, Tsuyoshi Hayashi, Tsutomu Sato, Yasushi Sato, Rishu Takimoto & Junji Kato. (2013) Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Journal of Gastroenterology 48:11, pages 1249-1258.
Crossref
Crossref
JINYAN ZHAO, WEI LIN, ZHIYUN CAO, LIYA LIU, QUNCHUAN ZHUANG, XIAOYONG ZHONG, ZHENFENG HONG & JUN PENG. (2013) Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma. Oncology Reports 30:3, pages 1309-1314.
Crossref
Crossref
Masato Fujii, Yuichiro Shibazaki, Kyoko Wakamatsu, Yutaka Honda, Yusuke Kawauchi, Kenji Suzuki, Somasundaram Arumugam, Kenichi Watanabe, Takafumi Ichida, Hitoshi Asakura & Hiroyuki Yoneyama. (2013) A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma. Medical Molecular Morphology 46:3, pages 141-152.
Crossref
Crossref
Ahmed O. Kaseb, Junichi Shindoh, Yehuda Z. Patt, Robert E. Roses, Giuseppe Zimmitti, Richard D. Lozano, Manal M. Hassan, Hesham M. Hassabo, Steven A. Curley, Thomas A. Aloia, James L. Abbruzzese & Jean-Nicolas Vauthey. (2013) Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma. Cancer 119:18, pages 3334-3342.
Crossref
Crossref
Wen-Jing He, Ming-Yan Xu, Rui-Rui Xu, Xiao-Qiong Zhou, Jun-Jie Ouyang, Hui Han & Geng-Zhen Chen. (2013) Inpatients' Knowledge about Primary Liver Cancer and Hepatitis. Asian Pacific Journal of Cancer Prevention 14:8, pages 4913-4918.
Crossref
Crossref
Whei-Mei Jean Shih, Ping-Ju Hsiao, Min-Li Chen & Mei-Hsiang Lin. (2013) Experiences of Family of Patient with Newly Diagnosed Advanced Terminal Stage Hepatocellular Cancer. Asian Pacific Journal of Cancer Prevention 14:8, pages 4655-4660.
Crossref
Crossref
BO TANG, YANG LI, LIANG ZHAO, SHENGGUANG YUAN, ZHENRAN WANG, BO LI & QIAN CHEN. (2013) Stable isotope dimethyl labeling combined with LTQ mass spectrometric detection, a quantitative proteomics technology used in liver cancer research. Biomedical Reports 1:4, pages 549-554.
Crossref
Crossref
Ania Z. Kielar, Rebecca M. Hibbert & Katherine E. Maturen. (2013) Imaging after Local Tumor Therapies: Kidney and Liver. Seminars in Roentgenology 48:3, pages 273-284.
Crossref
Crossref
B Zhang, L-W Dong, Y-X Tan, J Zhang, Y-F Pan, C Yang, M-H Li, Z-W Ding, L-J Liu, T-Y Jiang, J-H Yang & H-Y Wang. (2013) Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma. British Journal of Cancer 109:1, pages 14-23.
Crossref
Crossref
Amilcare Parisi, Jacopo Desiderio, Stefano Trastulli, Elisa Castellani, Rosario Pasquale, Roberto Cirocchi, Carlo Boselli & Giuseppe Noya. (2013) Liver resection versus radiofrequency ablation in the treatment of cirrhotic patients with hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 12:3, pages 270-277.
Crossref
Crossref
A Aigelsreiter, A L Ress, K Bettermann, S Schauer, K Koller, F Eisner, T Kiesslich, T Stojakovic, H Samonigg, P Kornprat, C Lackner, J Haybaeck & M Pichler. (2013) Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma. British Journal of Cancer 108:9, pages 1830-1837.
Crossref
Crossref
Yun Zhang, Tian-Zhou Zha, Ben-Shun Hu, Chao Jiang, Zhi-Jun Ge, Kai Zhang & Yong-Fei Tan. (2013) High expression of ADAM8 correlates with poor prognosis in hepatocellular carcinoma. The Surgeon 11:2, pages 67-71.
Crossref
Crossref
Wei Li, Hong-Xin Cai, Xu-Ming Ge, Kai Li, Wei-Dong Xu & Wei-Hong Shi. (2012) Prognostic significance of BMP7 as an oncogene in hepatocellular carcinoma. Tumor Biology 34:2, pages 669-674.
Crossref
Crossref
Xiangmei Chen, Ling Zhang, Ting Zhang, Meili Hao, Xiaolei Zhang, Jiangbo Zhang, Qing Xie, Yongfeng Wang, Mingzhou Guo, Hui Zhuang & Fengmin Lu. (2013)
Methylation‐mediated repression of micro
RNA
129‐2 enhances oncogenic
SOX
4 expression in
HCC
. Liver International 33:3, pages 476-486.
Crossref
Crossref
Galal El-Gazzaz, Achuthan Sourianarayanane, KV Narayanan Menon, Juan Sanabria, Koji Hashimoto, Cristiano Quintini, Dympna Kelly, Bijan Eghtesad, Charles Miller, John Fung & Federico Aucejo. (2013) Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies. Hepatobiliary & Pancreatic Diseases International 12:1, pages 34-41.
Crossref
Crossref
Ben-Shun Hu, Gang Zhao, Hai-Feng Yu, Ke Chen, Jia-Hong Dong & Jing-Wang Tan. (2012) High expression of AP-4 predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy. Tumor Biology 34:1, pages 271-276.
Crossref
Crossref
KAI SONG, JUNHUA WU & CHUNPING JIANG. (2012) Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review). Oncology Reports 29:1, pages 3-12.
Crossref
Crossref
Christian Steinberg, Suzanne Boudreau, Felix Leveille, Marc Lamothe, Patrick Chagnon & Isabelle Boulais. (2013) Advanced Hepatocellular Carcinoma with Subtotal Occlusion of the Inferior Vena Cava and a Right Atrial Mass. Case Reports in Vascular Medicine 2013, pages 1-6.
Crossref
Crossref
Huan Tong, Xiao Li, Chun Le Zhang, Jin Hang Gao, Shi Lei Wen, Zhi Yin Huang, Fu Qiang Wen, Ping Fu & Cheng Wei Tang. (2013) Transcatheter arterial embolization followed by octreotide and celecoxib synergistically prolongs survival of rabbits with hepatic VX2 allografts. Journal of Digestive Diseases 14:1, pages 29-37.
Crossref
Crossref
Yun Zhang, Yong-Fei Tan, Chao Jiang, Kai Zhang, Tian-Zhou Zha & Miao Zhang. (2012) High ADAM8 Expression is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma. Pathology & Oncology Research 19:1, pages 79-88.
Crossref
Crossref
Chao Jiang, Yun Zhang, Hai-Feng Yu, Xiao-Tian Yu, Su-Jun Zhou & Yong-Fei Tan. (2012) Expression of ADAM8 and its clinical values in diagnosis and prognosis of hepatocellular carcinoma. Tumor Biology 33:6, pages 2167-2172.
Crossref
Crossref
Siwei Wei, Yuliana Suryani, G. A. Nagana Gowda, Nicholas Skill, Mary Maluccio & Daniel Raftery. (2012) Differentiating Hepatocellular Carcinoma from Hepatitis C Using Metabolite Profiling. Metabolites 2:4, pages 701-716.
Crossref
Crossref
SHIH-CHANG TSAI, JAI-SING YANG, SHU-FEN PENG, CHI-CHENG LU, JO-HUA CHIANG, JING-GUNG CHUNG, MENG-WEI LIN, JEN-KUN LIN, SAKAE AMAGAYA, CINDERELLA WAI-SHAN CHUNG, THENG-THANG TUNG, WEN-WEN HUANG & MICHAEL T. TSENG. (2012) Bufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cells. International Journal of Oncology 41:4, pages 1431-1442.
Crossref
Crossref
Vianney Bouygues, Philippe Compagnon, Marianne Latournerie, Edouard Bardou-Jacquet, Christophe Camus, Mohamed Lakehal, Bernard Meunier & Karim Boudjema. (2012) MELD-based graft allocation system fails to improve liver transplantation efficacy in a single-center intent-to-treat analysis. Clinics and Research in Hepatology and Gastroenterology 36:5, pages 464-472.
Crossref
Crossref
Cho Rok Lee, Jin Hong Lim, Sung Hoon Kim, Sang Hoon Ahn, Young Nyun Park, Gi Hong Choi, Jin Sub Choi & Kyung Sik Kim. (2012) A Comparative Analysis of Hepatocellular Carcinoma after Hepatic Resection in Young versus Elderly Patients. Journal of Gastrointestinal Surgery 16:9, pages 1736-1743.
Crossref
Crossref
Yu Zhang, Jun Li, Lu Cao, Wen Xu & Zhengfeng Yin. (2012) Circulating Tumor Cells in Hepatocellular Carcinoma: Detection Techniques, Clinical Implications, and Future Perspectives. Seminars in Oncology 39:4, pages 449-460.
Crossref
Crossref
Wei-ming Fu, Jin-fang Zhang, Hua Wang, Zhi-chao Xi, Wei-mao Wang, Peng Zhuang, Xiao Zhu, Shih-chi Chen, Tak-ming Chan, Kwong-Sak Leung, Gang Lu, Hong-Xi Xu & Hsiang-fu Kung. (2012) Heat shock protein 27 mediates the effect of 1,3,5-trihydroxy-13,13-dimethyl-2H-pyran [7,6-b] xanthone on mitochondrial apoptosis in hepatocellular carcinoma. Journal of Proteomics 75:15, pages 4833-4843.
Crossref
Crossref
Lea-Yea Chuang, Jinn-Yuh Guh, Louis Kuoping Chao, Ying-Chen Lu, Jean-Yu Hwang, Yu-Lin Yang, Tsan-Hwang Cheng, Wan-Yu Yang, Ying-Jiun Chien & Jau-Shyang Huang. (2012) Anti-proliferative effects of cinnamaldehyde on human hepatoma cell lines. Food Chemistry 133:4, pages 1603-1610.
Crossref
Crossref
Qiujin Shen, Jia Fan, Xin-Rong Yang, Yexiong Tan, Weifeng Zhao, Yang Xu, Ning Wang, Yongdong Niu, Zheng Wu, Jian Zhou, Shuang-Jian Qiu, Ying-Hong Shi, Bin Yu, Ning Tang, Wei Chu, Min Wang, Jinhua Wu, Zhigang Zhang, Shengli Yang, Jianren Gu, Hongyang Wang & Wenxin Qin. (2012) Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. The Lancet Oncology 13:8, pages 817-826.
Crossref
Crossref
Kyung Eun Kim, Mi-Suk Park, Stuart Bentley-Hibbert, Song-Ee Baek, Young Chul Kim, Myeong-Jin Kim, Ki Whang Kim & Yong H. Auh. (2011) Hepatocellular carcinoma: clinical and radiological findings in patients with chronic B viral hepatitis and chronic C viral hepatitis. Abdominal Imaging 37:4, pages 591-594.
Crossref
Crossref
David Y. Zhang & Scott L. Friedman. (2012) Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology 56:2, pages 769-775.
Crossref
Crossref
Young Eun Chon, Eun Suk Jung, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Chae Yoon Chon, Kyu Sik Jung & Seung Up Kim. (2012) The Accuracy of Noninvasive Methods in Predicting the Development of Hepatocellular Carcinoma and Hepatic Decompensation in Patients With Chronic Hepatitis B. Journal of Clinical Gastroenterology 46:6, pages 518-525.
Crossref
Crossref
Gisselle Gallego, John F.P. Bridges, Terry Flynn, Barri M. Blauvelt & Louis W. Niessen. (2012) USING BEST-WORST SCALING IN HORIZON SCANNING FOR HEPATOCELLULAR CARCINOMA TECHNOLOGIES. International Journal of Technology Assessment in Health Care 28:3, pages 339-346.
Crossref
Crossref
Onur Yaprak, Murat Akyildiz, Murat Dayangac, Baha Tolga Demirbas, Necdet Guler, Gulen Bulbul Dogusoy, Yildiray Yuzer & Yaman Tokat. (2012) AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 11:3, pages 256-261.
Crossref
Crossref
Hesan Luo, Zhongyi Dong, Jinjin Zou, Qin Zeng, Dehua Wu & Li Liu. (2011) Down‐regulation of RhoE is associated with progression and poor prognosis in hepatocellular carcinoma. Journal of Surgical Oncology 105:7, pages 699-704.
Crossref
Crossref
Dorothy M. French, Benjamin C. Lin, Manping Wang, Camellia Adams, Theresa Shek, Kathy Hötzel, Brad Bolon, Ronald Ferrando, Craig Blackmore, Kurt Schroeder, Luis A. Rodriguez, Maria Hristopoulos, Rayna Venook, Avi Ashkenazi & Luc R. Desnoyers. (2012) Targeting FGFR4 Inhibits Hepatocellular Carcinoma in Preclinical Mouse Models. PLoS ONE 7:5, pages e36713.
Crossref
Crossref
Sene Waly Raphael, Zhang Yangde & Chen YuXiang. (2012) Hepatocellular Carcinoma: Focus on Different Aspects of Management. ISRN Oncology 2012, pages 1-12.
Crossref
Crossref
Yuko Nagaoki, Hideyuki Hyogo, Hiroshi Aikata, Mio Tanaka, Noriaki Naeshiro, Takashi Nakahara, Yoji Honda, Daisuke Miyaki, Tomokazu Kawaoka, Shintaro Takaki, Akira Hiramatsu, Koji Waki, Michio Imamura, Yoshiiku Kawakami, Shoichi Takahashi & Kazuaki Chayama. (2012) Recent trend of clinical features in patients with hepatocellular carcinoma. Hepatology Research 42:4, pages 368-375.
Crossref
Crossref
Madhvi Patel, Mohamed I.F. Shariff, Nimzing G. Ladep, Andrew V. Thillainayagam, Howard C. Thomas, Shahid A. Khan & Simon D. Taylor-Robinson. (2012) Hepatocellular carcinoma: diagnostics and screening. Journal of Evaluation in Clinical Practice 18:2, pages 335-342.
Crossref
Crossref
Olorunseun O Ogunwobi, Ton Wang, Lucy Zhang & Chen Liu. (2012) Cyclooxygenase-2 and Akt mediate multiple growth-factor-induced epithelial-mesenchymal transition in human hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 27:3, pages 566-578.
Crossref
Crossref
Yasuo Fukuhara. (2012) Identification of cellular genes showing differential expression associated with hepatitis B virus infection. World Journal of Hepatology 4:4, pages 139.
Crossref
Crossref
Feng Fang, Lianyue Yang, Yiming Tao & Wei Qin. (2011) FBI‐1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo. Cancer 118:1, pages 134-146.
Crossref
Crossref
Mohamed I. F. Shariff & Simon D. Taylor‐Robinson. 2011. Clinical Dilemmas in Primary Liver Cancer. Clinical Dilemmas in Primary Liver Cancer
177
183
.
Nimzing G. Ladep. 2011. Clinical Dilemmas in Primary Liver Cancer. Clinical Dilemmas in Primary Liver Cancer
11
17
.
John FP Bridges, Gisselle Gallego & Barri M Blauvelt. (2011) Controlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needs. Health Research Policy and Systems 9:1.
Crossref
Crossref
Kathrin KlutzMichael J. WillhauckChristian DohmenNathalie WunderlichKerstin KnoopChristian ZachReingard Senekowitsch-SchmidtkeFranz-Josef GildehausSibylle ZieglerSebastian FürstBurkhard GökeErnst WagnerManfred OgrisChristine Spitzweg. (2011) Image-Guided Tumor-Selective Radioiodine Therapy of Liver Cancer After Systemic Nonviral Delivery of the Sodium Iodide Symporter Gene. Human Gene Therapy 22:12, pages 1563-1574.
Crossref
Crossref
M.-O. Riener. (2011) Diagnose von Tumoren der Leber und GallenwegeDiagnosis of tumours of the liver and the biliary tract. Der Pathologe 32:S2, pages 304-309.
Crossref
Crossref
Xiaorong Zhao, Zhen Yu, Wentao Dai, Zhenjiang Yao, Wei Zhou, Weiping Zhou, Junli Zhou, Yonggang Yang, Yinchang Zhu, Sidong Chen & Limin Cao. (2011) Construction and characterization of an anti-asialoglycoprotein receptor single-chain variable-fragment-targeted melittin. Biotechnology and Applied Biochemistry 58:6, pages 405-411.
Crossref
Crossref
Sen-Yung Hsieh, Jung-Ru He, Ming-Chin Yu, Wei-Chen Lee, Tse-Chin Chen, Shao-Jung Lo, Rabindranath Bera, Chang-Mung Sung & Cheng-Tang Chiu. (2011) Secreted ERBB3 Isoforms Are Serum Markers for Early Hepatoma in Patients with Chronic Hepatitis and Cirrhosis. Journal of Proteome Research 10:10, pages 4715-4724.
Crossref
Crossref
Jian-zhong Di, Xiao-dong Han, Wen-ye Gu, Yu Wang, Qi Zheng, Pin Zhang, Hui-min Wu & Zhong-zheng Zhu. (2011) Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinoma. Journal of Zhejiang University SCIENCE B 12:10, pages 805-811.
Crossref
Crossref
Adnan Taş, Seyfettin Köklü, Yavuz Beyazit, Gökhan Karaca, H. Müzeyyen Astarcı, Erdem Akbal, Erdem Koçak, Güler Topçu & Ibrahim C. Haznedaroglu. (2011) Percutaneous ankaferd injection to in vivo liver tissue in comparison to ethanol in an experimental rat model. Clinics and Research in Hepatology and Gastroenterology 35:8-9, pages 549-553.
Crossref
Crossref
Jianxia Jiang, Hongjie Zhang, Qiyun Tang, Bo Hao & Ruihua Shi. (2011) Expression of HIWI in Human Hepatocellular Carcinoma. Cell Biochemistry and Biophysics 61:1, pages 53-58.
Crossref
Crossref
Florian Hucke, Wolfgang Sieghart, Maximilian Schöniger-Hekele, Markus Peck-Radosavljevic & Christian Müller. (2011) Clinical characteristics of patients with hepatocellular carcinoma in Austria – is there a need for a structured screening program?Klinische Charakteristika von Patienten mit hepatozellulärem Karzinom in Österreich – ist ein strukturiertes Screeningprogramm notwendig?. Wiener klinische Wochenschrift 123:17-18, pages 542-551.
Crossref
Crossref
Xiangyi Liu, Xiaohua Wan, Zhongwu Li, Changqing Lin, Yutao Zhan & Xinxin Lu. (2011) Golgi protein 73(GP73), a useful serum marker in liver diseases. Clinical Chemistry and Laboratory Medicine (CCLM) 49:8, pages 1311-1316.
Crossref
Crossref
Qi Xia, An-mei Deng, Shan-shan Wu & Min Zheng. (2011) Cholera toxin inhibits human hepatocarcinoma cell proliferation in vitro via suppressing ATX/LPA axis. Acta Pharmacologica Sinica 32:8, pages 1055-1062.
Crossref
Crossref
Yongliang Sun, Huayu Yang, Yilei Mao, Haifeng Xu, Jinchun Zhang, Guangbing Li, Xin Lu, Xinting Sang, Haitao Zhao, Shouxian Zhong, Jiefu Huang & Hongbing Zhang. (2011) Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival. Journal of Gastroenterology and Hepatology 26:7, pages 1207-1212.
Crossref
Crossref
Displaying 200 of 215 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list